DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling by 吏��뿄�쁺
ARTICLE
DCDC2 Mutations Cause a Renal-Hepatic
Ciliopathy by Disrupting Wnt Signaling
Markus Schueler,1,20 Daniela A. Braun,1,20 Gayathri Chandrasekar,2,20 Heon Yung Gee,1,20
Timothy D. Klasson,3 Jan Halbritter,1 Andrea Bieder,2 Jonathan D. Porath,1 Rannar Airik,1
Weibin Zhou,4 Joseph J. LoTurco,5 Alicia Che,5 Edgar A. Otto,4 Detlef Bo¨ckenhauer,6 Neil J. Sebire,7
Tomas Honzik,8 Peter C. Harris,9 Sarah J. Koon,9 Meral Gunay-Aygun,10 Sophie Saunier,11
Klaus Zerres,12 Nadina Ortiz Bruechle,12 Joost P.H. Drenth,13 Laurence Pelletier,14,15 Isabel Tapia-Pa´ez,2
Richard P. Lifton,16,17 Rachel H. Giles,3 Juha Kere,2,18,19,* and Friedhelm Hildebrandt1,17,*
Nephronophthisis-related ciliopathies (NPHP-RC) are recessive diseases characterized by renal dysplasia or degeneration. We here iden-
tify mutations of DCDC2 as causing a renal-hepatic ciliopathy. DCDC2 localizes to the ciliary axoneme and to mitotic spindle fibers in a
cell-cycle-dependent manner. Knockdown of Dcdc2 in IMCD3 cells disrupts ciliogenesis, which is rescued by wild-type (WT) human
DCDC2, but not by constructs that reflect human mutations. We show that DCDC2 interacts with DVL and DCDC2 overexpression in-
hibits b-catenin-dependent Wnt signaling in an effect additive to Wnt inhibitors. Mutations detected in human NPHP-RC lack these
effects. A Wnt inhibitor likewise restores ciliogenesis in 3D IMCD3 cultures, emphasizing the importance of Wnt signaling for renal
tubulogenesis. Knockdown of dcdc2 in zebrafish recapitulates NPHP-RC phenotypes, including renal cysts and hydrocephalus, which
is rescued by a Wnt inhibitor and by WT, but not by mutant, DCDC2. We thus demonstrate a central role of Wnt signaling in the path-
ogenesis of NPHP-RC, suggesting an avenue for potential treatment of NPHP-RC.Introduction
Cilia aremicrotubule-based structures that project from the
cell surface of numerous mammalian cells andmediate key
pathways of development such as Wnt and Shh signaling.
Many ciliary proteins participate in functional protein sub-
complexes,1 which localize to primary cilia, centrosomes,
the mitotic spindle, or the abscission structure in a cell-cy-
cle-dependent manner.2 Mutations in genes that encode
these ciliary proteins lead to developmental and degenera-
tive diseases, which show a broad phenotypic spectrum.
This complex of disorders has collectively been termed
‘‘ciliopathies’’ due to their localization to primary cilia
and centrosomes.3 Moreover, numerous cilia-mediated
signaling pathways have been implicated in the pathogen-
esis of ciliopathies, such as canonical Wnt/b-catenin,4
Shh,5 and DNA damage response (DDR).6,7
In this context, the term nephronophthisis-related
ciliopathies (NPHP-RC) summarizes a group of rare auto-
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The Anophthisis (NPHP [MIM 256100]), Senior-Loken syndrome
(SLS [MIM 266900]), Joubert syndrome (JBTS [MIM
213300]), and Meckel Gruber syndrome (MKS [MIM
249000]). NPHP accounts for the majority of genetically
caused end-stage renal disease (ESRD) during the first three
decades of life. The most prominent diagnostic hallmarks
are increased echogenicity and the presence of corticome-
dullary cysts upon renal ultrasound. Histologically, NPHP
is characterized by tubular atrophy, basement membrane
disintegration, interstitial fibrosis, and cyst formation.
About 15% of the affected individuals with NPHP-RC
exhibit extrarenal organ involvement, in particular hepa-
tobiliary ductal plate malformation, progressive retinal
dystrophy, and cerebellar vermis hypoplasia/aplasia as
the hallmark of JBTS. The most severe manifestation of
the NPHP-RC spectrum is MKS, a perinatally lethal
ciliopathy.
Similar to the vast pleiotropy, NPHP-RC show broadly
heterogeneous genotypes with monogenic ciliopathies es-
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than 90 genes.3–5,8–15 We recently demonstrated in a large
cohort of 1,056 families with NPHP-RC that in more than
50%of cases theunderlyingdisease-causingmutation isun-
known.16,17 In order to identify additional single gene
causes of NHPH-RC, we here applied homozygosity map-
ping and whole-exome sequencing in 100 affected individ-
uals of consanguineousparents or sibling cases fulfilling the
diagnostic criteria of NPHP-RC. In combination with high-
throughput exon sequencing in a cohort of 800 individuals
with NPHP-RC, we identified recessive truncating muta-
tions in DCDC2 as a hitherto unknown cause of renal-he-
patic variant of NPHP-RC. We demonstrate that DCDC2
interacts with the mediator of Wnt signaling dishevelled,
and that DCDC2 overexpression inhibits b-catenin-depen-
dent Wnt signaling. Thus, we demonstrate a central role
ofWnt signaling in the pathogenesis of NPHP-RC, suggest-
ing an avenue for potential treatment of NPHP-RC.Material and Methods
Research Subjects
Blood samples and pedigrees were obtained from individuals with
diagnosed NPHP-RC and informed consent. Approval for human
subject research was obtained from Institutional Review Boards
of the University of Michigan and the Boston Children’s Hospital.
Linkage Analysis
For genome-wide homozygosity mapping GeneChip Human
Mapping 250k StyI Array (Affymetrix) was used. Regions of
homozygosity were identified using GENEHUNTER 2.118,19 and
ALLEGRO20 with a disease allele frequency of 0.0001 and marker
allele frequencies of European descent.12,21
Whole-Exome Sequencing
Whole exome sequencing (WES) and variant burden analysis was
performed as previously described22 using Agilent SureSelect hu-
man exome capture arrays (Life TechnologiesTM) with next gener-
ation sequencing (NGS) on an IlluminaTM sequencing platform.
Sequence reads were mapped against the human reference
genome (NCBI build 36/hg18) using CLC Genomics Workbench
(version 4.7.2) software (CLC bio). Mutation calling (Tables S1
and S2) was performed by geneticists/cell biologists, who had
knowledge of clinical phenotypes, pedigree structure, homozygos-
ity mapping, and WES evaluation.
High-Throughput Mutation Analysis by Array-Based
Multiplex PCR and NGS
For 48 DNA samples simultaneously, 672 amplicons (592 exons) of
32 candidate genes, includingDCDC2, were sequenced in a cohort
of 800 individuals with NPHP-RC using a PCR-based 48.48 Access
Array microfluidic technology (Fluidigm) with consecutive NGS as
previously described.16,17 Detected variants were confirmed by
Sanger sequencing and evaluated for segregation. Additional 21
individuals with early onset liver fibrosis were Sanger sequenced
for coding regions of DCDC2 (Table S3).
cDNA and Splice Mutation
RNA of A4435-21 and healthy control was purified from whole
blood, cDNA was synthesized (Agilent Technologies) and Sanger82 The American Journal of Human Genetics 96, 81–92, January 8, 20sequenced, using primers flanking exon 4 in order to confirm skip-
ping of exon 4 (Figure S1; Table S3).cDNA Cloning
Human full-length (Hs-FL) DCDC2 cDNA was subcloned
by PCR from Hs-FL cDNA (origene SC114336). Full-length
and partial clones were subcloned into pRK5-N-Myc using
the gateway system (Invitrogen). Mutations were introduced
at position c.649A>T to represent p.Lys217* (Figure S2C)
and at c.123_124 delGT to represent p.Ser42Glnfs*72
(Figure S2A) using ‘‘QuikChange II XL Site-Directed Mutagen-
esis’’ (Agilent Technologies). Using the same technique the
nucleotides 349 to 425 of exon 4 were deleted in order to
represent the splice mutation c.349-2A>G (Figure S2B). MAP-
K8IP1 (JIP1) full-length was subcloned from Hs-FL cDNA
(NM_005456, origen sc124125) into pDEST40 (gateway).
PAFAH1B1 (LIS1) (NM_000430.3 [MIM 601545]), open reading
frame was amplified from Hs-FL cDNA (clone ID
HsCD00378475) and subcloned to pDEST40. Human Dishev-
eled 1,2,3 (NM_004421.2, NM_004422.2, NM_004423.3) full-
length clones and fragment of DVL3 were a gift from Vita
Bryja, Masaryk University.Coimmunoprecipitation
Coimmunoprecipitation experiments upon co-overexpression
in NIH 3T3 and HEK293T cells were performed as described
previously.23Luciferase Reporter Gene Assay
The Wnt/b-catenin reporter assay has been performed as
described.23 In brief, NIH 3T3 cells were transfected with
pcDNA3/S33Y b-catenin, pTOPFLASH, pGL4.74[hRluc/TK] (Prom-
ega) and DCDC2 (WT/mutants) or the empty vectors. At 36 hr
posttransfection, luciferase activities were measured using a
Dual-Luciferase Reporter Assay and GloMaxTM 96 microplate
luminometer (Promega) according manufacturer’s instruction.
The luciferase activities were normalized to Renilla luciferase activ-
ities and protein concentration.Antibodies
For immunofluorescence studies, the following primary anti-
bodies were used: Mouse anti-DCDC2 (Abcam, ab 157186),
goat-anti-DCDC2 (Santa Cruz, sc-50728), rabbit anti-Kif3a
(Abcam ab11259), mouse anti-Jip-1 (Santa Cruz sc-25267),
mouse anti-DVL3 (Santa Cruz sc-365581), mouse anti-SDCCAG8
(Abcam, ab67098), rabbit anti-Cep164 (Sigma, hpa037606),
mouse anti-Pericentrin (Abcam, ab28144), rabbit anti-PCNT
(Atlas Antibodies, 019887), rabbit anti-PCM-1 (Cell Signaling,
5259), and rabbit anti-IFT88 (ProteinTech, 13967-1-AP). For
immunoblotting, the following primary antibodies were used:
rabbit anti-DCDC2 (Sigma Aldrich D2945), and mouse anti-Jip-
1 (Santa Cruz sc-25267).Immunofluorescence and Confocal Microscopy in
Cell Lines
Cells were prepared for immunofluorescence as previously
described24, incubated in primary antibodies (see above) over-
night at 4C, and imaged using Leica SP5X systemwith an upright
DM6000 microscope and A1R confocal microscope (Nikon
Instruments).15
Immunofluorescence and Confocal Microscopy on
Tissues
Human and murine paraffin-embedded samples were obtained
from Zyagen. Paraffin-embedded tissue sections of 5–7 mm were
deparaffinized, rehydrated, stained after heat-induced antigen
retrieval, and imaged on a LSM510 confocalmicroscope (Carl Zeiss
Microimaging), and on an A1R confocal microscope (Nikon
Instruments).
Knockdown of Dcdc2
Transfection of non-target siRNA was performed in parallel to tar-
geted siRNA using Lipofectamine RNAimax (Invitrogen) following
manufacturer’s instructions. Experiments were performed 48 hr
after siRNA transfection. For all knockdown experiments, Dhar-
macon ON-TARGETplus siRNA 11 and 12 against murine Dcdc2a
were used (Table S3). The knockdown efficiency was shown by
immunoblot (Figure S12) and by qPCR (Figure S10).
Spheroid Assay
Spheroid assays were performed as previously described.6 In brief,
IMCD3 cells were transfected with human DCDC2 cDNA con-
structs at day 1. After 24 hr, cells were transfected with siRNA
against murine Dcdc2a. 24 hr after the second transfection, cells
were resuspended in matrigel (BD Bioscience) and seeded on Lab
TekII chambered coverglasses. After 72 hr, cells that had formed
spheroids with visible cleared lumens were stained and imaged us-
ing a Zeiss LSM700 confocal microscope. In each spheroid, nuclei
were counted, followed by cilia. The percentage of ‘‘ciliated nuclei’’
in each spheroid was used as a distinct value in the results. To
detect the presence of cilia, we scored 200–2,000 cells per condi-
tion for the presence of cilia. GraphPad Prism 6.0 (GraphPad Soft-
ware) was used to graph results and perform statistical tests using
ANOVA statistical analysis. Experiments were repeated at least two
times independently and data combined, graphs showmean value
and SEM.
Zebrafish Embryos and Microinjections of
Morpholinos and mRNA
Zebrafish embryos were staged 24 hr post fertilization (hpf) and 1-
phenyl-2-thiourea (PTU, Sigma) was used to block pigmentation
in embryos older than 24 hpf. A morpholinooligonucleotide
(MO) against the translation start site of dcdc2b (AUGMO) (Table
S3) was designed (Gene Tools, LLC), dissolved in 13 Danieau’s
buffer and injected at varying concentrations (50, 100, 150, 200,
and 250 mM) into WT zebrafish embryos at the one-cell stage. 50-
capped sense mRNA of human DCDC2 WT and the two mutant
clones hDCDC2_Lys217* and hDCDC2_Ser42Glnfs*72 were syn-
thesized using SP6 mMessage mMachine Kit (Ambion) and was
coinjected (approximately 100 pg) with dcdc2b MO for rescue ex-
periments. Two additional MOs targeting splice sites were not effi-
cient in dcdc2b knockdown as evidenced by RT PCR (data not
shown). All zebrafish experiments were performed in accordance
with ethical permits approved by Stockholm North Experimental
Animal Committee (Dnr N29-12).
Treatment with WNT/b-Catenin Inhibitor iCRT14
Zebrafish embryos injected with AUGMOwere exposed to 500 nM
or 750 nM or 1 mMor 5 mM concentrations of iCRT14 at the begin-
ning of gastrulation. Compound treated embryos were raised at
28.5C in Petri dishes for 48 hr and screened for the rescue of cili-
opathy phenotypes. As solvent control, 1% DMSO was used.The AWhole-Mount In Situ Hybridization, Histology, and
Immunohistochemistry
Digoxigenin-labeled antisense probe for foxa3 was synthesized as
described previously.25 For in situ hybridization staged embryos
were fixed in 4% PFA for 24 hr and processed.26 Immunohisto-
chemistry and histology experiments on Zebrafish embryos have
been performed as described.27,28
Transmission Electron Microscopy
For electron microscopy, 3.5-day-old control and morphant em-
bryos were fixed in 2% glutaraldehyde solution containing 1%
PFA in 0.1 M phosphate buffer (PB), pH 7.4. Sectioning was per-
formed using a Leica EM UC 6 (Leica) and stained with uranyl ac-
etate and lead citrate. Electron micrographs were examined and
acquired using a Tecnai 10 transmission electron microscope
with a veleta camera.
Statistical Analysis
Results in Figure 2 are presented as scattergrams with means and
error bars for SD for the indicated number of values. Statistical
analysis of continuous data was performed with a two-tailed
Student’s t test. p < 0.05 was considered statistically significant.
Bioinformatics
Genetic location is according to the February 2009 Human
Genome Browser data.Results
DCDC2 Mutations Cause a Renal-Hepatic Ciliopathy
To elucidate pathomechanisms of NPHP-RC, we sought
additional causative mutations and performed homozy-
gosity mapping21 and whole-exome sequencing24 in 100
consanguineous cases or sibling cases fulfilling the diag-
nostic criteria of NPHP-RC. In consanguineous individual
A3547-22, who had hepatic fibrosis (Figure 1A) at age
11 months and end-stage renal disease (ESRD) from
NPHP at age 14 years (Table 1), we obtained by homozygos-
ity mapping eight candidate regions of homozygosity by
descent (Figure 1B). Whole-exome sequencing yielded a
homozygous truncating mutation (c.649A>T, p.Lys217*)
in DCDC2 (double cortin domain-containing 2) (Figures
1C–1E; Table 1). No additional homozygous truncating
mutations were detected in any other gene within the
mapped candidate regions (Tables S1 and S2). Direct in-
spection of sequence alignments did not yield a mutation
in any of the >90 genes with a known connection to
NPHP-RC. By high-throughput exon sequencing16,17 in a
large worldwide cohort of 800 additional families with
NPHP-RC, in whom mutations in known genes were
excluded, we sequenced all exons of DCDC2. In less than
ten of these individuals liver fibrosis was present. We de-
tected in individual A4435-21, who had hepatic fibrosis
requiring liver transplantation at 2 years of age, two com-
pound heterozygous mutations: A frameshift mutation
(c.123_124 delGT, p.Ser42Glnfs*72) (Table 1; Figure 1E)
and an obligatory splice site mutation (c.349-2A>G) that
we show produces the frameshift product p.Val117Leufs*merican Journal of Human Genetics 96, 81–92, January 8, 2015 83
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Figure 1. Homozygosity Mapping and WES Detect DCDC2 Mutations in Individuals with Renal-Hepatic Ciliopathy
(A) In A3547-22 with a renal-hepatic ciliopathy renal histology (left panel; Masson trichrome staining) reveals tubulointerstitial fibrosis
and tubular dilation with epithelial luminal budding (arrowhead). Hepatic histology (right panel; H&E staining) of A3547-22 shows
areas of florid fibrosis with destruction of bile ducts, focal ductular proliferation with cholestasis, and bile plugging.
(B) For individual A3547-22 nonparametric LOD (NPL) scores fromwhole-genomemapping are plotted across the human genome. The x
axis shows Affymetrix 250K StyI array SNP positions on human chromosomes concatenated from pter (left) to qter (right). Genetic dis-
tance is given in cM. Eight maximum NPL peaks (red circles) indicate candidate regions of homozygosity by descent. Note that the
DCDC2 locus (arrow head) is positioned within a maximum NPL peaks on chromosome 6p.
(C) Exon structure of human DCDC2 cDNA. Positions of start codon (ATG) and stop codon (TGA) are indicated.
(D) Protein domain structure of DCDC2. The N terminus contains two doublecortin domains.
(legend continued on next page)
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54 (Table 1; Figure 1F; Figures S1 and S2). None of the
affected individuals had retinal degeneration, cerebellar
vermis hypoplasia, hydrocephalus, obesity, or bone dis-
ease. An additional 21 individuals with early onset liver
fibrosis were screened for variants in the coding region of
DCDC2 by Sanger sequencing (Table S3). No additional
mutations were detected. We generated cDNA clones re-
flecting the human DCDC2 mutations (Figure S2). When
re-evaluating the Dcdc2 knockout mouse model,29 we
found that there was periportal fibrosis at age 11 months
consistent with the phenotype seen in humans with
DCDC2 mutations (Figure S3).
DCDC2 Colocalizes with Other NPHP-RC Proteins to
the Cilia-Centrosome-Spindle Complex
To elucidate the role of DCDC2 in the pathogenesis of
NPHP-RC, we examined its localization in epithelia of
different tissues that are involved in NPHP-RC pheno-
types, using indirect immunofluorescence studies. In
kidney and liver, we observed that DCDC2 colocalizes
with acetylated a-tubulin to the axoneme of primary cilia
of human renal tubule cells and cholangiocytes in liver
(Figure 1G) and to multiciliated ependymal cells and pia
mater cells in mouse brain (Figure S4). However, DCDC2
did not localize to the basal body (Figure S4).
Because NPHP-RC proteins localize to primary cilia, cen-
trosomes, the mitotic spindle, and the abscission structure
in a cell-cycle-dependent manner,2 we performed colocali-
zation studies for DCDC2 and other NPHP-RC proteins
using confocal laser immunofluorescence microscopy in
MDCK-II and hTERT-RPE1 cells (Figures S6 and S7). We
found that within the different phases of mitosis DCDC2
fully or partially colocalizes with acetylated a-tubulin
during metaphase and anaphase to the spindle microtu-
bules, during late telophase/diakinesis to the abscission
structure, and in ciliated cells during interphase to the
ciliary axoneme (Figures S5–S7). Throughout those cell-cy-
clephases,DCDC2 is excluded fromthebasalbody (in inter-
phase) and the mitotic spindle poles (in metaphase and
anaphase), as well as the midbody (in diakinesis) (Figures
S5–S7), in contrast to other NPHP-RC proteins, which
preferentially stain basal body and spindle poles, recipro-
cally omitting the axoneme and mitotic spindle fibers.
These NPHP-RC proteins include SDCCAG8/NPHP10
(Figure S6) and CEP164/NPHP15 (Figure S7). Inmetaphase,
DCDC2 is absent from the interpolar spindle domain of the(E) Three homozygous (H) or compound-heterozygous (h) DCDC2 m
(see Table 1). Family number (underlined), mutation, and predicted
shown underneath.
(F) Sequenced RT-PCR product from cDNA of lymphocytes of A443
located in exons 2 (2F) and 5 (5R). Positions of primers are indicated
(G) Hepatic and renal localization of DCDC2. Coimmunofluorescen
onstrates DCDC2 at the ciliary axoneme in cilia of cholangiocytes (u
orescence was performed on human paraffin embedded sections. Nu
(H) Upon overexpression in NIH 3T3 cells WT DCDC2 decorates the
tions in NPHP-RC families lack ciliary localization.
(I) Quantitation of ciliary staining in 50 transfected cells per clone. S
The Amitotic spindle (Figure S5). Three proteins that had been
described as interacting with DCDC2, DVL3 (this study),
JIP1,30 and Kif3a31 labeled basal bodies, mitotic spindle
poles, and midbody rather than the ciliary axoneme
(Figure S8).
Overexpression in hTERT-RPE1 cells revealed upon
immunofluorescence that mutations observed in individ-
uals with NPHP-RC and constructs, from which either
of the two doublecortin domains are deleted (Figure S2)
fail to localize to the primary cilia (Figure S9). These results
are in accordance to observations made in rat hippo-
campal neurons.31 Immunocytochemistry of cells overex-
pressing WT and the truncating mutants p.Lys217*,
p.Val117Leufs*54, and p.Ser42Glnfs*72 shows that the
mutations abrogate localization of DCDC2 to the primary
cilium in NIH 3T3 (Figure 1H) and RPE1 cells (Figure S9).
DCDC2 Interacts with DVL1-3, and Mutations
Abrogate Wnt Signaling
Because we have previously shown that INVS4,32 and
CEP164,6 defects in which are associated with NPHP-RC,
interact with proteins that participate in Wnt signaling,
we tested whether DCDC2 interacts with the disheveled
proteins (DVL1, DVL2, or DVL3), which act as regulators
of Wnt signaling.31,33
We performed coimmunoprecipitation studies in NIH
3T3 cells demonstrating that full-length DCDC2 interacts
with all three dishevelled proteins, DVL1, DVL2, and
DVL3. This interaction was not abrogated in cDNA
constructs representing the mutations that we identified
in individuals with NPHP-RC (Figure S11). However, a
construct (aa 222-476) lacking both doublecortin (DCX)
domains (see Figure S2) failed to interact with DVL3,
whereas deletion of either DCX domain alone did not
abrogate interaction with DVL3 (Figure 2A). (An overview
on cDNA clones is given in Figure S2, where p.Ser42Glnfs*
72 represents the shortest variant of A4435-21).
As DVL regulates Wnt signaling, we examined signaling
effects downstream of DCDC2 and found that siRNA
knockdown of Dcdc2a in NIH 3T3 cells increases b-cate-
nin-induced activation of T cell factor (TCF)-dependent
transcription (Figure 2B). Reciprocally, overexpression of
DCDC2 WT reduced b-catenin-induced activation of
TCF-dependent transcription (Figure 2C, left panel).
This effect was abrogated by all three mutations (Table 1,
Figures 1C–1E) that we detected in individuals withutations detected in two families with a renal-hepatic ciliopathy
translational changes are indicated. Healthy control sequence is
5-21 with obligatory splice mutation (c.349-2A>G) using primers
in (C).
ce using anti-DCDC2 or anti-a-acetylated tubulin antibodies dem-
pper panel) and of renal epithelial cells (lower panel). Immunoflu-
clei are stained with DRAQ5. Scale bars are 20 mm.
ciliary axoneme, whereas all three mutant clones reflecting muta-
cale bars are 5 mM.
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itors (FH535 and iCRT14) reduced b-catenin-induced
activation of TCF-dependent transcription with an effect
that was additive when combined with DCDC2 overex-
pression (Figure 2C, middle and right panels).
DCDC2 Interacts with JIP1
Previous studies showed that DCDC2 interacts with
the protein JIP1 (mitogen-activated protein kinase 8
interacting protein 1).30,34 JIP1 plays a role in aggregating
components of the MAP kinase module (MLK, MKK7,
JNK), in facilitating JNK signal transduction35 activating
JNK,36 thereby mediating MAPK activation. We therefore
performed coimmunoprecipitation in HEK293T cells
(Figure S12A). Whereas WT DCDC2 and the mutant
p.Val117Leufs*54 still interacted with full-length JIP1,
the DCDC2 truncated mutant p.Ser42Glnfs*72 that we
had detected in individual A4435-21 lacked interaction
with JIP1. (For DCDC2 constructs see Figure S2.) When
phosphorylation of the JNK downstream targets c-Jun
and ATF2 was assayed in NIH 3T3 cells, knockdown of
DCDC2 in NIH 3T3 cells did not affect JNK pathway activa-
tion (Figure S12B). It was previously shown that lissence-
phaly-1 (LIS1) interacts with doublecortin (DCX), a protein
that belongs with DCDC2 to a family of doublecortin
domain-containing proteins.37 When performing coim-
munoprecipitation to test for interaction of DCDC2 with
LIS1 we did not detect an interaction between the two
proteins (Figure S13).
Loss of Dcdc2 Function Disturbs Renal Epithelial
Ciliation in 3D Cultures
In order to test the effects of DCDC2 on ciliation, we as-
sessed the result of Dcdc2 siRNA knockdown in a 3D cell
culture system. IMCD3 cells cultured in 3Dmatrigel mimic
the normal processes of renal tubulogenesis by forming
spheroids or small tubules composed of polarized cells,
which exhibit a lumen and a ciliated apical membrane.
Counting the number of cilia present on this apical mem-
brane is an established model of ciliogenesis.38 Spheroids
grown from cells treated with two different RNAi oligonu-
cleotides targeted against Dcdc2 displayed significantly
fewer cilia than spheroids grown from cells treated with a
non-target control RNAi but did not display any severe
architectural changes in lumen formation (Figure 3). In
both cases, this ciliation defect could be rescued by concur-
rent transfection of WT human DCDC2 but not by any of
the mutant DCDC2 clones Ser42Glnfs*72 and Val117-
Leufs*54 that were derived from the affected individuals
(Figures 3A–3C). The third mutant (Lys217*) was not effi-
ciently expressed in the spheroids. The overexpression of
empty vector, humanWTDCDC2, or either of the mutants
did not produce a significant difference in ciliation,
excluding a dominant-negative or overexpression effect
caused by these alleles (Figure 3; Figure S10). We conclude
that DCDC2 is important for the generation and mainte-
nance of renal cilia, but knockdown of DCDC2 does not15
A B
C
Figure 2. DCDC2 Interacts with Dishev-
elled and Inhibits b-Catenin-Dependent
Wnt Signaling Synergistically with Wnt
Inhibitors
(A) DCDC2 interacts with DVL3 when
both are transiently overexpressed in NIH
3T3 cells. A construct (aa 222-476) lacking
both doublecortin (DCX) domains (see
Figure S2 for constructs) does not interact
with DVL3, whereas the deletion of either
DCX domain alone is not sufficient to
abrogate the interaction.
(B) Knockdown of DCDC2 in NIH 3T3
activates the b-catenin-dependent WNT
pathway. Cells were transfected with an
empty vector pcDNA3 (Control) or
pcDNA3-S33Y-b-catenin together with
scrambled or DCDC2 siRNA. The ratio be-
tween the luciferase activity obtained
from the cotransfected TCF-responsive re-
porter and the control luciferase reporter
gene construct (pGL4.74[hRluc/YK]) was
calculated and designated as ‘‘TCF reporter
activity.’’
(C) Cells were transfected with an empty
vector pcDNA3 (Control) or pcDNA3-
S33Y-b-catenin (Mock) together with
DCDC2 constructs. Left panel: Overexpres-
sion of WT, but not mutant, DCDC2 in-
hibits b-catenin-induced activation of
TCF-dependent reporter gene. Light gray
panel: The Wnt inhibitor FH535 sup-
presses TCF reporter activity. Overexpres-
sion of WT DCDC2, but not three mutant
DCDC2 clones, inhibits TCF reporter activ-
ity additively to the effect of FH535. Dark
gray panel: Likewise, the Wnt inhibitor
iCRT14 suppresses TCF reporter activity.
Overexpression of WT DCDC2, but not
mutants, inhibits TCF reporter activity
additively to the effect of iCRT14. Two
cDNA clones lacking the first or second
DCX domain, respectively (D1st DCX and
D2nd DCX), also fail to suppress TCF re-
porter activity. A dotted horizontal line is
drawn for easier interpretation of results.
[ indicates two outliers at 2.4 and 2.7.
aFH535 (middle light gray panel) is known
to suppress b-catenin/TCF-mediated tran-
scription and to inhibit b-catenin and GRIP-1 recruitment to PPARg; biCRT14 (left dark gray panel) is known to modulate interaction
between b-catenin and TCF and inhibit b-catenin/TCF-mediated transcription.recapitulate the spheroid defects commonly observed after
the loss of function of other NPHP proteins.1,24
Because loss of Dcdc2 constitutively activates Wnt
signaling (Figure 2B), we hypothesized that treating
spheroids grown from renal cells depleted for Dcdc2 with
Wnt inhibitors would restore the frequency of cilia. We
grew IMCD3 spheroids in the presence of either 50 nM
FH535 or 100 nM iCRT14 for 72 hr and scored for cilia
per nucleus in 3D structures. The cells exposed to 50 nM
FH535 failed to thrive and resulted in no viable spheroids
(data not shown). However, the cells treated with 100 nM
iCRT14 did generate well-polarized spheroids with lu-
mens. The Wnt inhibitor treatment noticeably rescued
the effects of Dcdc2 knockdown in the cells growing in
3D structures by restoring cilia numbers (Figures 3C andThe A3D). This suggests a role for Wnt signaling in the process
of ciliation.
Dcdc2 Knockdown Replicates Ciliopathy Phenotypes
in Zebrafish
To examine the renal cystic phenotype in an in vivo verte-
bratemodel, we studied loss-of-function of dcdc2b in zebra-
fish using a morpholino targeted against the start codon
(AUGMO) to suppress the translation of dcdc2b mRNA.
The knockdown efficiency of the AUGMO was dose
dependent, producing clear visible phenotypes in higher
percentage of embryos at 200 mM. In comparison with
WT control embryos, knockdown of dcdc2b resulted in
typical ciliopathy-related defects such as ventrally curved
body axis, hydrocephalus, kidney cysts, kinky tails, andmerican Journal of Human Genetics 96, 81–92, January 8, 2015 87
A B
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Figure 3. Lack of Dcdc2 Is Rescued by Full-Length DCDC2 and by Wnt Inhibition, but Not by Mutants Detected in NPHP-RC
(A) siRNA (siDcdc2-11) mediated knockdown of Dcdc2 in IMCD3 cells grown in 3D spheroid culture causes a ciliogenesis defect that is
rescued by overexpression of humanWT DCDC2, but not by mutants found in humans with NPHP-RC. For each condition >50 spher-
oids were evaluated for the percentage of ciliated cells and the experiment was repeated three times independently. Note that the red
structures visible in the mutant-transfected spheroid are midbodies of dividing cells, not cilia. Scale bars are 5 mm.
(B) Ratio of ciliated cells per nuclei within each spheroid upon knockdown and after attempted rescue with WT DCDC2 and two
mutants. *p < 0.001, as determined by ANOVA analysis. Experiments were repeated at least two times independently and the data
combined. Graphs show mean value and standard error of the mean (SEM).
(C) The ciliogenesis defect was rescued by growing spheroids in medium treated with Wnt inhibitor iCRT14 (100 mM). Scale bars are
5 mm.
(D) Quantification for two siRNAs of rescue of ciliogenesis defect by iCRT14 treatment. *p < 0.001, as determined by ANOVA analysis.
Experiments were repeated at least two times independently and the data combined. Graphs show mean value and SEM.occasionally pericardial edema (Figure 4). At 2 days postfer-
tilization (dpf), 81% of the morphants showed body-axis
defects with kinks or waviness in the tail (Figure 4A). Hy-
drocephalus was observed in 58% of morphants at 2 dpf,
and kidney cysts were prominantly visible in 31% of the
morphants at 3.5 dpf (Figures 4A–4C). In addition, dcdc2b
morphants also showed malformation in otolith assembly88 The American Journal of Human Genetics 96, 81–92, January 8, 20(Figure S14). Compared to control embryos that normally
had two otoliths, some of the dcdc2b morphants had one
or two fused or three otoliths (Figure S14F). These results
demonstrate that dcdc2b in zebrafish might have a vital
role in cilia formation or function.
We further observed that suppression of dcdc2b caused
laterality defects in liver, gut, and pancreas, which was15
AB
D
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Figure 4. MO Knockdown of dcdc2b Rep-
licates Ciliopathy Phenotypes in Zebrafish
that Cannot Be Rescued by cDNA Clones
Representing Human Ciliopathy Mutants
(A) Zebrafish embryos injected with
AUGMO at one-cell stage produced defects
characteristic of cilia dysfunction. Lateral
view of 2-day-old control and morphant
embryos. dcdc2b morphant developed
ventrally bent body axis, hydrocephalus,
tail kinks, and pericardial edema (‘‘full
ciliopathy phenotype’’). Morphologically
visible ciliopathy phenotypes in dcdc2b
morphants were completely or partially
rescued (lacking at least one phenotype)
by coinjection of 50capped mRNA of
WT human DCDC2. Coinjection
of AUGMO with capped mRNA of
either of the two human DCDC2
mutant clones hDCDC2_Lys217* or
hDCDC2_Ser42Glnfs*72 mostly failed to
rescue ciliary defects. Scale bar is 100 mm.
(B) Histological sections of pronephros
from control and morphant embryo at 3.5
dpf. dcdc2bmorphants clearly showed dila-
tion of the pronephric duct (asterisks)
compared to control embryos.
(C) Transverse brain sections shows hydro-
cephalus (asterisk) in dcdc2b morphants as
compared to control brain sections (methy-
lene blue and silver stain).
(D) Left-right asymmetry defects in liver,
gut, and pancreas as visualized by in situ
hybridization for the expression of foxa3
with quantitation by histogram (li, liver;
pa, pancreas; g, gut). Scale bar is 50 mm.
(E) Treatment with b-catenin inhibitor
iCRT14 within the dose range of 0.5–1 mM
rescued dcdc2b knockdown ciliopathy phe-
notypes in the morphants.
Histograms are representation of two or
three independent experiments.visualized by whole-mount in situ hybridization for the
expression of foxa3 (Figure 4D). Interestingly, immunohis-
tochemical staining with an anti-acetylated tubulin anti-
body revealed that knockdown of dcdc2b does not alter
motile cilia length in zebrafish kidney or spinal cord
(Figure S14A–S14D). Electronmicrographs of the motile
pronephric cilia of dcdc2b morphants showed no struc-
tural defects in comparison to WT pronephric cilia
(Figure S14E).The American Journal of HumTo confirm the specificity of the
phenotype and to determine whether
the biological function of DCDC2 is
evolutionarily conserved between hu-
man and zebrafish, we performed an
mRNA rescue experiment by coinject-
ing human WT DCDC2 mRNA along
with dcdc2b MO into one-cell-stage
embryos. Injection of WT human
DCDC2 mRNA rescued morphologi-
cally visible ciliary phenotypes in
51% of the morphants, suggestinga similar role for dcdc2b as for DCDC2 in cilia function
(Figure 4A). We further tested the pathogenicity of
the DCDC2 mutations identified in individuals diag-
nosed for NPHP-RC by a similar rescue approach where
dcdc2b MO was coinjected with capped mRNA of the
human mutation representing clones hDCDC2_Lys217*
or hDCDC2_Ser42Glnfs*72 into one-cell-stage embryos.
Both mutations were unable to completely rescue the
phenotype of dcdc2b morphants, confirming that thesean Genetics 96, 81–92, January 8, 2015 89
mutations indeed affect the function of the protein
(Figure 4A).Zebrafish Ciliopathy Phenotype Is Rescued by a
b-Catenin Inhibitor
Since knockdown or overexpression of Dcdc2 in NIH 3T3
cells altered the Wnt/b-catenin pathway, we hypothesized
that the ciliopathy phenotype observed in zebrafish dcdc2b
morphants might be a result of derailed Wnt signaling
pathway. To test this hypothesis, we exposed the mor-
phants to 0.5 mM, 0.75 mM, and 1 mM of a potent b-catenin
inhibitor, iCRT14 at the beginning of gastrulation. After
48 hr period of exposure, the embryos were scored for
body curvature, hydrocephalus, tail kinks, and pericardial
edema. Interestingly, iCRT14 was able to effectively rescue
the phenotype in higher percentage of embryos at doses
ranging from 0.5 to 1 mM (Figure 4E). However, concentra-
tions higher than 1 mMwere toxic to the embryos (data not
shown). Our in vivo and in vitro results strongly suggest a
role of Wnt signaling pathway in the pathogenesis of
NPHP-RC.Discussion
Wehere identifiedmutations ofDCDC2 as a previously un-
known cause of a renal-hepatic ciliopathy in humans that
is characterized by severe early-onset liver fibrosis within
the first year of life. DCDC2 localized to the ciliary
axoneme and to mitotic spindle fibers in a cell-cycle-
dependent manner. We showed that DCDC2 interacts
with DVL, and DCDC2 overexpression inhibited b-cate-
nin-dependent Wnt signaling in an effect additive to
Wnt inhibitors. Mutations detected in human NPHP-RC
lacked these effects. A Wnt inhibitor restored ciliogenesis
in 3D IMCD3 cultures, emphasizing the importance of
Wnt signaling for renal tubulogenesis. The fact that knock-
down of DCDC2 reduces the number of cilia in cell culture,
but not in dcdc2b zebrafishmorphants might be explained
by the biological differences between primary cilia of
IMCD3 cells and multiciliated, motile cilia of zebrafish
larval pronephric duct. Finally, knockdown of dcdc2b
in zebrafish recapitulated NPHP-RC phenotypes, which
were rescued by a Wnt inhibitor and by WT but not by
mutant DCDC2. We thus demonstrate a central role of
Wnt signaling in the pathogenesis of NPHP-RC, suggesting
an avenue for potential treatment of NPHP-RC.
Broad pleiotropy is a common feature of NPHP-RC. In
this context, the absence of renal involvement in individ-
ual A4435-21 at 9 years of age does not exclude that the
affected individual might develop renal involvement later
in life, because individual A3547-22 developed chronic
kidney disease at 14 years of age with no signs of renal
involvement earlier in life. Due to the significant overlap
of the observed phenotype with other forms of NPHP-RC
we introduce the term ‘‘NPHP19’’ for this variant of
NPHP-RC.90 The American Journal of Human Genetics 96, 81–92, January 8, 20By immunofluorescence studies, we show that DCDC2
localizes to the ciliary axoneme and to mitotic spindle fi-
bers. This localization pattern is clearly distinct from other
NPHP-RC proteins, such as CEP164 and SDCCAG8 (Figures
S6 and S7), which preferentially stain the basal body and
the mitotic spindle poles. Interestingly, the interaction
partners of DCDC2, DVL3 and JIP1,34 and KIF3a31 show
a localization pattern that resembles CEP164 and
SDCCAG8. The finding that there was no tight subcellular
colocalization for these proteins could be due to the
fact that the proteins bind to tubulin as suggested by
Figure S8. The specific subcellular compartments to which
NPHP-RC proteins localize are very small and often
extremely dynamic during different phases of cell cycle,
making colocalization experiments difficult to interpret.
This holds true for many of the >90 NPHP-RC that are
known so far.
Our in vitro studies in cell lines, spheroids, and our
in vivo studies in zebrafish clearly demonstrate a role
of increased canonical Wnt signaling in the pathogen-
esis of NPHP-RC. Loss-of-function mutations observed
in individuals with NPHP-RC fail to reduce canonical
Wnt signaling in vitro. The zebrafish phenotype
observed upon knockdown of dcdc2b is reminiscent of
the one seen in the zebrafish apc/ mutant, a model
of constitutively activated Wnt.39 The fact that the
phenotype of dcdc2b zebrafish morphants could be miti-
gated by treatment with Wnt inhibitors further supports
the significance of dysregulated canonical Wnt signaling
in this model.
Consistent with the observed human phenotype, our
histological studies of Dcdc2/ mice reveal periportal
liver fibrosis and demonstrate biliary duct proliferation
and extensive collagen deposition surrounding the portal
tracts compared to WT control (Figure S3). It has been
frequently reported that Wnt signaling regulates tubule
formation (reviewed in 40). Interestingly, the role of
Wnt/b-catenin signaling during the development of
liver fibrosis was recently analyzed.41 It was shown that
abnormal activation of Wnt/b-catenin signaling pro-
motes tissue fibrogenesis while downregulation of Wnt
signaling suppresses the activity of hepatic stellate cells
and the collagen synthesis. Our data suggest that loss of
DCDC2 function does not profoundly affect renal tubu-
logenesis but renders the tubules more responsive to
Wnt modulation in the 3D polarized tubule state. Acti-
vated Wnt signaling has so far been implicated in human
NPHP-RC in the presence of INVS mutations.4 Our
demonstration that Wnt inhibitors reverse the failure of
DCDC2 mutants to reduce canonical Wnt signaling
opens a potential route toward treatment for certain
forms of NPHP-RC.Supplemental Data
Supplemental Data include fourteen figures and three tables and
can be found with this article online at http://www.cell.com/ajhg.15
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